ABCL
AbCellera Biologics Inc.
1W: -3.7%
1M: +5.3%
3M: -8.9%
YTD: -1.2%
1Y: +30.9%
3Y: -55.2%
5Y: -89.2%
$3.39
+0.08 (+2.42%)
After Hours: $3.42 (+0.03, +1.03%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider+$15.4M
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.0B
52W Range1.891-6.515
Volume1,663,008
Avg Volume4,130,832
Beta0.87
Dividend—
Analyst Ratings
Company Info
CEOCarl Hansen
Employees596
SectorHealthcare
IndustryBiotechnology
IPO Date2020-12-11
Websiteabcellera.com
2215 Yukon Street
Vancouver, BC V5Y 0A1
CA
Vancouver, BC V5Y 0A1
CA
604 559 9005
About AbCellera Biologics Inc.
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
Latest News
AbCellera Biologics Inc. (NASDAQ:ABCL) Receives $7.75 Average Target Price from Brokerages
DNB Asset Management AS Buys Shares of 656,208 AbCellera Biologics Inc. $ABCL
AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Tops Revenue Estimates
AbCellera Biologics GAAP EPS of -$0.49 beats by $0.15, revenue of $75.1M beats by $38.81M
AbCellera Biologics Inc. (ABCL) Q4 2025 Earnings Call Transcript
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Thermopylae Holdings | P-Purchase | 38,000 | $3.44 | 2026-02-27 |
| Booth Andrew | P-Purchase | 42,600 | $3.42 | 2026-02-27 |
| Thermopylae Holdings | P-Purchase | 177,457 | $3.27 | 2026-02-26 |
| Booth Andrew | A-Award | 808,898 | $3.42 | 2026-01-01 |
| Hansen Carl L. G. | A-Award | 2,106,505 | $3.42 | 2026-01-01 |